Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
Brent L. Wood(University of Southern California), Ilan Kirsch(Adaptive Biotechnologies (United States)), Harlan Robins(Adaptive Biotechnologies (United States)), Charles Gawad(St. Jude Children's Research Hospital), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), Yunfeng Dai(University of Florida), Naomi Winick(The University of Texas Southwestern Medical Center), Kelly W. Maloney(Children's Hospital Colorado), Beryl Crossley(Adaptive Biotechnologies (United States)), William L. Carroll(NYU Langone Health), Meenakshi Devidas(National Institutes of Health), David Wu(University of Washington), Michael J. Borowitz(Johns Hopkins University), Mignon L. Loh(Seattle Children's Hospital), David Williamson(Illumina (United States)), Eric Larsen(New England Cancer Specialists)
Cited by 227
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k